Loading...
Loading...
COO| Name | Value |
|---|---|
| Revenues | 1,018.4M |
| Cost of Revenue | 340.7M |
| Gross Profit | 677.7M |
| Operating Expense | 479.3M |
| Operating I/L | 198.4M |
| Other Income/Expense | -29.8M |
| Interest Income | 0.0M |
| Pretax | 168.6M |
| Income Tax Expense | 51.1M |
| Net Income/Loss | 117.5M |
The Cooper Companies, Inc. develops, manufactures, and markets contact lenses through its CooperVision and CooperSurgical segments. CooperVision offers a range of spherical, toric, and multifocal lenses to correct various vision challenges globally. CooperSurgical focuses on family and women's health care, providing medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide.
